Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01738607
Other study ID # 010M69241
Secondary ID R01NR007756-01A2
Status Completed
Phase N/A
First received
Last updated
Start date April 2004
Est. completion date December 2010

Study information

Verified date May 2023
Source University of Minnesota
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary aim of this study was to compare the effects of supplementation with one of three dietary fibers (gum arabic, carboxy-methylcellulose, or psyllium) or a placebo on fecal incontinence (FI), symptom intolerance, and quality of life in community-living individuals who have incontinence of loose or liquid feces. A secondary aim was to explore the possible mechanism(s) underlying the supplements' efficacy (i.e., improvements in stool consistency, water-holding capacity or gel formation).


Recruitment information / eligibility

Status Completed
Enrollment 206
Est. completion date December 2010
Est. primary completion date June 2007
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - age =18 years - living in the community (not a nursing home or assisted living facility) - self-report of usually having FI of loose or liquid consistency at least twice in a 2-wk period - toilets independently - ability to read and write in English. - Persons that regularly performed pelvic floor muscle exercises and/or biofeedback on a maintenance regimen for at least 20 wks or who took a steady dose of anti-motility medications on a regular schedule that still met the FI criteria were also eligible. Exclusion Criteria: - difficulty swallowing, - a gastrointestinal (GI) tract altered by surgery, - a malabsorption disorder, - inflammatory bowel disease, - gastrointestinal cancer or active cancer treatment, - allergy to the fibers, - regularly used a laxative or enema, were tube-fed, or unwilling to discontinue taking periodic self-prescribed fiber supplements or anti-diarrheal medications. - a score =24 on the Mini Mental State Examination - having/reporting fewer than two episodes of FI or being incapable of performing study procedures during the run-in baseline period

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Psyllium

Gum Arabic
Gum acacia dietary fiber
carboxymethylcellulose
dietary fiber
Placebo


Locations

Country Name City State
United States University of Minnesota Minneapolis Minnesota

Sponsors (1)

Lead Sponsor Collaborator
University of Minnesota

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other self-reported rating of consistency of continent stools on a daily stool diary the Stool Consistency Classification System used was shown to be valid and reliable
Other usual diet intake written record of all food and drink consumed
Other report of additional fluid intake subjects checked whether the drank required amount of additional fluid and wrote the date and time of drinking
Other absorbent pad soiling subjects indicated number of absorbent products that were soiled on stool diary and and saved and returned them to be assessed by study team
Other self-report of any stools not collected reported on stool diary daily with reason for not collecting
Other Stool Color change date and time a stool color change was observed after swallowing a capsule with a decoy or marker dose of a food dye; date and time capsule was taken was also reported
Other in vitro fiber degradation nested experiment of in vitro degradation of each dietary fiber by stools of subjects using established procedure reported in Bliss, D.Z. et al. Nurs. Res. 2001, 50, 203-213.
Other total dietary fiber content of fiber sources used in Study established method of Theander O. et al. J AOAC Int. 1995;78(4):1030-44 used.
Other Personal Goals of Treatment for Fecal Incontinence and Satisfaction with Achievement of Goals data obtained by semi-structured interview
Other modifications of preparation of foods, diet intake, and eating pattern to manage fecal incontinence data obtained by semi-structured interview
Primary self-report of an incontinent episode on a daily stool diary the date and time of an incontinence episode was reported and the ratio of the number of incontinence episodes to total stools daily was calculated
Secondary self-report of gastro-intestinal symptoms on a daily symptom record The amount of GI symptoms reported were flatus, belching, bloating, abdominal cramping, nausea, a feeling of fullness, and stomach upset using a categorical scale. Number of times of flatus was also reported.
The amount of two obfuscating symptoms were also reported. headache and sleepiness.
How upsetting/bothersome the symptoms were were also reported.
Secondary self-report of quality of life The Fecal Incontinence Quality of Life tool (FIQL) was used; Rockwood, T.H. et al. Diseases of the Colon & Rectum. 2000;43(1):9-16.
Secondary Water-holding capacity of non-frozen of stools Measure was done on stools of 52 randomly selected subjects (13 from each group) Established method of Wenzl, H. et al. Gastroenterology. 1995;108(6):1729-38 used.
Secondary Gel formation of non-frozen stools Measure was done on stools of 52 randomly selected subjects (13 from each group); Established method of Fischer, M.H. et al.Carbohydrate Research 2004;339(11): 2009-2017.
Secondary Total dietary fiber content of feces Measured in composites of all stools from baseline and supplement periods and non-frozen stools
Established method of Theander O, et al. J AOAC Int. 1995;78(4):1030-44 used.
Secondary Self-report of amount of supplement consumed reported by fractions on supplement intake form and return of unconsumed portion was assessed by study team
Secondary amount of fecal incontinence subjects self-reported greatest amount of soiling (from soling of tissue between buttocks to shoes or floor)
Secondary wet and dry weights of collected stools and percentage of water content collected stools were weighed and freeze-dried to constant weight; percentage of water content was calculated from these values
See also
  Status Clinical Trial Phase
Recruiting NCT03825575 - Sacral Neuromodulation as Treatment for Fecal Incontinence N/A
Completed NCT00605826 - A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence N/A
Withdrawn NCT02208258 - Efficacy, Safety, and Performance Study of a Novel Device Designed to Manage Fecal Incontinence in Hospitalized Bedridden Patients With Liquid to Semi-formed Stool. N/A
Completed NCT01939821 - A Pilot Study to Evaluate Educational Programs to Improve Fecal Incontinence Care in Nursing Homes N/A
Completed NCT01957969 - French Post-Inscription Study on Sacral Neuromodulation in the Treatment of Fecal Incontinence N/A
Completed NCT01710579 - Normal Values in Ano-rectal 3D High Resolution Manometry N/A
Recruiting NCT00530933 - Tibial Nerve Stimulation for Faecal Incontinence N/A
Completed NCT00565136 - Evaluation of Outcomes of Restoring Pelvic Floor Support With TOPAS in Women With Moderate Fecal Incontinence Symptoms Phase 1/Phase 2
Withdrawn NCT00522691 - Efficacy of Sacral Nerve Stimulation Before Definitive Implantation N/A
Completed NCT00677508 - Development of an Instrument to Measure Quality of Life in Children With Chronic Constipation and Soiling
Completed NCT05032534 - Examination of a New Irrigation System for Transanal Irrigation in Children With Fecal Incontinence N/A
Completed NCT05058326 - Severity of Fecal Incontinence and Manometric Values Using the Anopress® Device in Women
Completed NCT03746834 - NASHA/Dx as a Perianal Implant for the Treatment of Persistent Fecal Incontience After Anorectal Malformation Phase 4
Completed NCT00124904 - Biofeedback for Fecal Incontinence N/A
Completed NCT03028636 - LIBERATE - PRO: Eclipseâ„¢ System Registry
Completed NCT04097288 - Effects of Single Dose Citalopram and Reboxetine on Urethral and Anal Closure Function on Healthy Female Subjects Phase 1
Completed NCT05621629 - Management of FI After Surgery of ARM
Withdrawn NCT04138602 - BTL Emsella Chair Versus Sham for the Treatment of Fecal Incontinence N/A
Completed NCT03252951 - Physical Therapy for Anal Incontinence N/A
Completed NCT04478799 - Transcutaneous Posterior Nerve Stimulation inTreatment of Fecal Incontience N/A